Alistair Ring

1.2k total citations
12 papers, 371 citations indexed

About

Alistair Ring is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Alistair Ring has authored 12 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Alistair Ring's work include Advanced Breast Cancer Therapies (4 papers), Cancer Risks and Factors (3 papers) and Cancer Treatment and Pharmacology (3 papers). Alistair Ring is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cancer Risks and Factors (3 papers) and Cancer Treatment and Pharmacology (3 papers). Alistair Ring collaborates with scholars based in United Kingdom, Italy and France. Alistair Ring's co-authors include Ian E. Smith, Eleni Galani, Catherine Shannon, Alison Jones, Peter Ellis, Juliet Wright, Sophie McGrath, Peter Harper, Gavin Marx and Christopher Steer and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Supportive Care in Cancer.

In The Last Decade

Alistair Ring

11 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alistair Ring United Kingdom	7	248	131	80	76	49	12	371
Sara Ekberg Sweden	15	197 0.8×	42 0.3×	49 0.6×	48 0.6×	8 0.2×	50	514
Philippe Rauch France	11	294 1.2×	85 0.6×	71 0.9×	31 0.4×	11 0.2×	22	563
Darlene Dale Canada	6	242 1.0×	88 0.7×	54 0.7×	9 0.1×	23 0.5×	6	556
A Kurkure India	9	243 1.0×	97 0.7×	81 1.0×	11 0.1×	13 0.3×	13	426
Mark Allen United States	6	449 1.8×	126 1.0×	35 0.4×	58 0.8×	16 0.3×	22	615
Chenjie Zeng United States	7	156 0.6×	32 0.2×	39 0.5×	15 0.2×	19 0.4×	12	369
Janelle M. Fauci United States	9	204 0.8×	47 0.4×	31 0.4×	44 0.6×	6 0.1×	19	366
Farhana Badar Pakistan	16	296 1.2×	130 1.0×	73 0.9×	39 0.5×	3 0.1×	46	543
Irina Ghislain Belgium	6	230 0.9×	28 0.2×	27 0.3×	43 0.6×	28 0.6×	7	327
Capucine Baldini France	10	184 0.7×	24 0.2×	43 0.5×	25 0.3×	93 1.9×	19	336

Countries citing papers authored by Alistair Ring

Since Specialization

Citations

This map shows the geographic impact of Alistair Ring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Ring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Ring more than expected).

Fields of papers citing papers by Alistair Ring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Ring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Ring. The network helps show where Alistair Ring may publish in the future.

Co-authorship network of co-authors of Alistair Ring

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Ring. A scholar is included among the top collaborators of Alistair Ring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Ring. Alistair Ring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hurvitz, Sara A., Michał Jarząb, Montserrat Muñoz-Mateu, et al.. (2025). Abstract P4-09-22: Distant disease-free survival (DDFS) across key subgroups from the phase 3 NATALEE trial of ribociclib (RIB) plus a nonsteroidal aromatase inhibitor (NSAI) in patients with HR+/HER2− early breast cancer (EBC). Clinical Cancer Research. 31(12_Supplement). P4–9.

Ring, Alistair, Meghan Karuturi, Emily Nash Smyth, et al.. (2023). Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice. Drugs - Real World Outcomes. 10(4). 589–603. 2 indexed citations

Laurentiis, Michelino De, Simona Borštnar, Mario Campone, et al.. (2020). Updated results from the phase IIIb complement-1 study of ribociclib (RIB) plus letrozole (LET) in the treatment of HR+, HER2-advanced breast cancer (ABC).. Journal of Clinical Oncology. 38(15_suppl). 1055–1055. 1 indexed citations

Laurentiis, Michelino De, Patrick Neven, Guy Jérusalem, et al.. (2018). Ribociclib (RIBO) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) with no prior endocrine therapy (ET) for ABC: Preliminary results from the phase 3b CompLEEment-1 trial.. Journal of Clinical Oncology. 36(15_suppl). 1056–1056. 3 indexed citations

Pallis, Athanasios, Sigrid Hatse, Barbara Brouwers, et al.. (2013). Evaluating the physiological reserves of older patients with cancer: The value of potential biomarkers of aging?. Journal of Geriatric Oncology. 5(2). 204–218. 56 indexed citations

Wildiers, Hans, Étienne Brain, Björn Penninckx, et al.. (2012). The EORTC Cancer in the Elderly Task Force, a Protostar for EORTC's future. European Journal of Cancer Supplements. 10(1). 34–38. 8 indexed citations

Wright, Juliet, et al.. (2010). The treatment of co-morbidities in older patients with metastatic cancer. Supportive Care in Cancer. 18(5). 651–655. 38 indexed citations

McGrath, Sophie & Alistair Ring. (2010). Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists. Therapeutic Advances in Medical Oncology. 3(2). 73–83. 20 indexed citations

Ring, Alistair, et al.. (2008). A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer. Patient. 1(2). 105–113. 13 indexed citations

10.

Ring, Alistair. (2007). Breast cancer and pregnancy. The Breast. 16. 155–158. 4 indexed citations

11.

Ring, Alistair, Ian E. Smith, Alison Jones, et al.. (2005). Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching Hospitals. Journal of Clinical Oncology. 23(18). 4192–4197. 187 indexed citations

12.

Ring, Alistair, Gavin Marx, Christopher Steer, & Peter Harper. (2002). Influenza vaccination and chemotherapy: a shot in the dark?. Supportive Care in Cancer. 10(6). 462–465. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact